(VIANEWS) - J & J Snack Foods Corp. (JJSF), BlackRock (BLK), American Financial Group (AFG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. J & J Snack Foods Corp. (JJSF)
23.8% sales growth and 5.26% return on equity
J & J Snack Foods Corp. manufactures, markets, and distributes various nutritional snack foods and beverages to the food service and retail supermarket industries in the United States, Mexico, and Canada.
J & J Snack Foods Corp.'s sales growth this year is anticipated to be 11% and 8.7% for next year.
Year-on-year quarterly revenue growth grew by 51.2%, now sitting on 1.07B for the twelve trailing months.
Volume
Today's last reported volume for J & J Snack Foods Corp. is 33166 which is 42.64% below its average volume of 57826.
J & J Snack Foods Corp.'s sales growth for the next quarter is 23.8%. The company's growth estimates for the ongoing quarter and the next is 217.5% and 900%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.26%.
Volatility
J & J Snack Foods Corp.'s last day, last week, and last month's current intraday variation average was 1.52%, 1.44%, and 0.99%, respectively.
J & J Snack Foods Corp.'s highest amplitude of average volatility was 2.24% (day), 2.70% (last week), and 2.02% (last month), respectively.
J & J Snack Foods Corp.'s Stock Yearly Top and Bottom Value
J & J Snack Foods Corp.'s stock is valued at $148.67 at 15:22 EST, way below its 52-week high of $181.71 and higher than its 52-week low of $140.27.
J & J Snack Foods Corp.'s Moving Average
J & J Snack Foods Corp.'s value is below its 50-day moving average of $153.09 and below its 200-day moving average of $162.00.2. BlackRock (BLK)
16% sales growth and 16.78% return on equity
BlackRock, Inc. is a publicly owned investment manager.
BlackRock's sales growth this year is expected to be 18.9% and 9.5% for next year.
Year-on-year quarterly revenue growth grew by 32.1%, now sitting on 18.07B for the twelve trailing months.
Volume
Today's last reported volume for BlackRock is 677574 which is 37.27% above its average volume of 493600.
BlackRock's sales growth for the next quarter is 16%. The company's growth estimates for the present quarter and the next is 6.1% and 4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.78%.
Volatility
BlackRock's last day, last week, and last month's current intraday variation average was 1.87%, 1.10%, and 0.86%, respectively.
BlackRock's highest amplitude of average volatility was 2.62% (day), 1.74% (last week), and 1.67% (last month), respectively.
BlackRock's Stock Yearly Top and Bottom Value
BlackRock's stock is valued at $922.77 at 15:22 EST, below its 52-week high of $971.78 and way higher than its 52-week low of $654.87.
BlackRock's Moving Average
BlackRock's value is above its 50-day moving average of $894.89 and above its 200-day moving average of $885.28.3. American Financial Group (AFG)
15.5% sales growth and 24.18% return on equity
American Financial Group, Inc., an insurance holding company, provides property and casualty insurance products in the United States.
American Financial Group's sales growth this year is anticipated to be 5.1% and 11.7% for next year.
Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 8.51B for the twelve trailing months.
Volume
Today's last reported volume for American Financial Group is 318254 which is 0.87% above its average volume of 315492.
American Financial Group's sales growth for the next quarter is 15.5%. The company's growth estimates for the current quarter and the next is a negative 5.2% and 1.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.18%.
Volatility
American Financial Group's last day, last week, and last month's current intraday variation average was 3.70%, 1.21%, and 1.30%, respectively.
American Financial Group's highest amplitude of average volatility was 2.11% (day), 1.55% (last week), and 1.83% (last month), respectively.
American Financial Group's Stock Yearly Top and Bottom Value
American Financial Group's stock is valued at $139.88 at 15:22 EST, under its 52-week high of $146.63 and way higher than its 52-week low of $79.21.
American Financial Group's Moving Average
American Financial Group's worth is higher than its 50-day moving average of $136.03 and above its 200-day moving average of $131.04.4. Haemonetics Corporation (HAE)
15.3% sales growth and 4.57% return on equity
Haemonetics Corporation, a healthcare company, provides hematology products and solutions.
Haemonetics Corporation's sales growth this year is expected to be 14.6% and 3.5% for next year.
Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 933.83M for the twelve trailing months.
Volume
Today's last reported volume for Haemonetics Corporation is 386360 which is 16.79% below its average volume of 464346.
Haemonetics Corporation's sales growth is a negative 0% for the present quarter and 15.3% for the next. The company's growth estimates for the present quarter and the next is a negative 9.9% and 52.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.57%.
Volatility
Haemonetics Corporation's last day, last week, and last month's current intraday variation average was 3.56%, 5.93%, and 3.07%, respectively.
Haemonetics Corporation's highest amplitude of average volatility was 4.96% (day), 5.66% (last week), and 4.03% (last month), respectively.
Haemonetics Corporation's Stock Yearly Top and Bottom Value
Haemonetics Corporation's stock is valued at $57.90 at 15:22 EST, way under its 52-week high of $142.11 and way higher than its 52-week low of $49.26.
Haemonetics Corporation's Moving Average
Haemonetics Corporation's value is way below its 50-day moving average of $68.92 and below its 200-day moving average of $63.34.5. AudioCodes Ltd. (AUDC)
10.5% sales growth and 16.67% return on equity
AudioCodes Ltd., together with its subsidiaries, provides advanced communications software, products, and productivity solutions for the digital workplace.
AudioCodes Ltd.'s sales growth this year is anticipated to be 11.7% and 11.9% for next year.
Year-on-year quarterly revenue growth grew by 13.2%, now sitting on 234.64M for the twelve trailing months.
Volume
Today's last reported volume for AudioCodes Ltd. is 74024 which is 28.31% below its average volume of 103260.
AudioCodes Ltd.'s sales growth for the next quarter is 10.5%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative -9.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.67%.
Volatility
AudioCodes Ltd.'s last day, last week, and last month's current intraday variation average was 0.36%, 0.93%, and 1.14%, respectively.
AudioCodes Ltd.'s highest amplitude of average volatility was 1.33% (day), 1.90% (last week), and 2.57% (last month), respectively.
AudioCodes Ltd.'s Stock Yearly Top and Bottom Value
AudioCodes Ltd.'s stock is valued at $36.93 at 15:22 EST, below its 52-week high of $37.35 and way above its 52-week low of $25.90.
AudioCodes Ltd.'s Moving Average
AudioCodes Ltd.'s value is above its 50-day moving average of $34.62 and way higher than its 200-day moving average of $33.10.6. LeMaitre Vascular (LMAT)
10.5% sales growth and 13.54% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
LeMaitre Vascular's sales growth this year is expected to be 19.7% and 7.8% for next year.
Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 152.47M for the twelve trailing months.
Volume
Today's last reported volume for LeMaitre Vascular is 103813 which is 2.75% below its average volume of 106753.
LeMaitre Vascular's sales growth for the next quarter is 10.5%. The company's growth estimates for the present quarter and the next is a negative 8.8% and 7.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.54%.
Volatility
LeMaitre Vascular's last day, last week, and last month's current intraday variation average was 0.24%, 0.94%, and 1.42%, respectively.
LeMaitre Vascular's highest amplitude of average volatility was 3.51% (day), 2.75% (last week), and 3.10% (last month), respectively.
LeMaitre Vascular's Stock Yearly Top and Bottom Value
LeMaitre Vascular's stock is valued at $51.58 at 15:22 EST, way below its 52-week high of $64.50 and way higher than its 52-week low of $34.23.